Understanding mutational processes in human cancer
13 Jul 2016
Understanding mutational processes in human cancer
Mouse models of lung cancer
'Rewiring' tumour susceptibility
Deciphering RAS/MAPK signalling in cancer
Models and critical preclinical data shaping personal therapy
Characterisation of somatic mutations using patient RNASeq profiles
WIN 2016 highlights: Changing the understanding of cancer
Systems thinking in the future of personalised medicine
New targets in personalised therapy for patients with lung cancer
A global perspective on infections related to cancer
MetAL trial for prostate cancer
Germline mutations influence risk and recovery throughout life